Abstract

Sterol-induced binding of endoplasmic reticulum (ER) membrane proteins Insig-1 and Insig-2 to SREBP cleavage-activating protein (Scap) and HMG-CoA reductase triggers regulatory events that limit cholesterol synthesis in animal cells. Binding of Insigs to Scap prevents proteolytic activation of sterol-regulatory element binding proteins (SREBPs), membrane-bound transcription factors that enhance cholesterol synthesis, by trapping Scap-SREBP complexes in the ER. Insig binding to reductase causes ubiquitination and subsequent proteasome-mediated degradation of the enzyme from ER membranes, slowing a rate-limiting step in cholesterol synthesis. Here, we report the characterization of mutant Chinese hamster ovary cells, designated SRD-20, that are resistant to 25-hydroxycholesterol, which potently inhibits SREBP activation and stimulates degradation of reductase. SRD-20 cells were produced by mutagenesis of Insig-1-deficient SRD-14 cells, followed by selection in 25-hydroxycholesterol. DNA sequencing reveals that SRD-20 cells harbor a point mutation in one Insig-2 allele that results in production of a truncated, nonfunctional protein, whereas the other allele contains a point mutation that results in substitution of glutamic acid for glycine-39. This glycine residue localizes to the first membrane-spanning segment of Insig-2 and is also present in the corresponding region of Insig-1. Mutant forms of Insig-1 and Insig-2 containing the Glu-to-Gly substitution fail to confer sterol regulation upon overexpressed Scap and reductase. These studies identify the intramembrane glycine as a key residue for normal sterol regulation in animal cells.

Highlights

  • Sterol-induced binding of endoplasmic reticulum (ER) membrane proteins Insig-1 and Insig-2 to sterol-regulatory element binding protein (SREBP) cleavage-activating protein (Scap) and HMG-CoA reductase triggers regulatory events that limit cholesterol synthesis in animal cells

  • To identify amino acids in Insig-2 that are important for sterol-mediated effects on SREBP cleavage-activating protein (Scap) and reductase, Insig-1-deficient sterol regulatory deficient (SRD)-14 cells were mutagenized with ethylmethane sulfonate (EMS), followed by selection for growth in medium containing 5% lipoprotein-deficient serum and 1 ␮g/ml 25-HC

  • Processed forms of SREBP-2 accumulated in the nuclear extracts of sterol-depleted Chinese hamster ovary (CHO)-7, SRD-14, SRD-15, and SRD-20 cells

Read more

Summary

Introduction

Sterol-induced binding of endoplasmic reticulum (ER) membrane proteins Insig-1 and Insig-2 to SREBP cleavage-activating protein (Scap) and HMG-CoA reductase triggers regulatory events that limit cholesterol synthesis in animal cells. Insig-1 and Insig-2, closely related membrane proteins of the endoplasmic reticulum (ER), control cholesterol synthesis in mammalian cells through their regulated binding to the membrane proteins SREBP cleavage-activating protein (Scap) and HMG-CoA reductase [1]. Scap mediates the activation of sterol-regulatory element binding proteins (SREBPs), membrane-bound transcription factors that enhance transcription of genes encoding cholesterol biosynthetic enzymes [2]. Excess sterols trigger binding of Insigs to reductase, resulting in recruitment of a membrane-bound ubiquitin ligase called gp that initiates ubiquitination and subsequent proteasomal degradation of reductase from ER membranes [6, 7] This sterol-accelerated degradation markedly slows the rate at which mevalonate is produced.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.